146 related articles for article (PubMed ID: 30699183)
21. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.
Levin VA; Yung WK; Bruner J; Kyritsis A; Leeds N; Gleason MJ; Hess KR; Meyers CA; Ictech SA; Chang E; Maor MH
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):58-66. PubMed ID: 12007942
[TBL] [Abstract][Full Text] [Related]
22. CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.
Miettinen H; Kononen J; Sallinen P; Alho H; Helen P; Helin H; Kalimo H; Paljärvi L; Isola J; Haapasalo H
J Neurooncol; 1999 Feb; 41(3):205-11. PubMed ID: 10359140
[TBL] [Abstract][Full Text] [Related]
23. Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis.
Jairam V; Kann BH; Park HS; Miccio JA; Beckta JM; Yu JB; Prabhu RS; Gao SJ; Mehta MP; Curran WJ; Bindra RS; Contessa JN; Patel KR
Anticancer Res; 2019 Jun; 39(6):2911-2918. PubMed ID: 31177129
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of prognostic factors on survival in patients with low grade glioma.
Durmaz R; Vural M; Işildi E; Coşan E; Ozkara E; Bal C; Ciftçi E; Arslantaş A; Atasoy MA
Turk Neurosurg; 2008 Oct; 18(4):336-44. PubMed ID: 19107679
[TBL] [Abstract][Full Text] [Related]
25. Combined treatment modality for anaplastic oligodendroglioma: a phase II study.
Jeremic B; Shibamoto Y; Gruijicic D; Milicic B; Stojanovic M; Nikolic N; Dagovic A; Aleksandrovic J
J Neurooncol; 1999 Jun; 43(2):179-85. PubMed ID: 10533731
[TBL] [Abstract][Full Text] [Related]
26. Machine Learning for Better Prognostic Stratification and Driver Gene Identification Using Somatic Copy Number Variations in Anaplastic Oligodendroglioma.
Rosenberg S; Ducray F; Alentorn A; Dehais C; Elarouci N; Kamoun A; Marie Y; Tanguy ML; De Reynies A; Mokhtari K; Figarella-Branger D; Delattre JY; Idbaih A;
Oncologist; 2018 Dec; 23(12):1500-1510. PubMed ID: 30018130
[TBL] [Abstract][Full Text] [Related]
27. Fractionated stereotactic radiation therapy in the management of primary oligodendroglioma and oligoastrocytoma.
Combs SE; Schulz-Ertner D; Thilmann C; Edler L; Debus J
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):797-802. PubMed ID: 15936562
[TBL] [Abstract][Full Text] [Related]
28. Racial disparities in anaplastic oligodendroglioma: An analysis on 1643 patients.
Shin JY; Yoon JK; Diaz AZ
J Clin Neurosci; 2017 Mar; 37():34-39. PubMed ID: 28024733
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Factors Associated With Survival in Patients With Diffuse Astrocytoma.
Liu S; Liu X; Zhuang W
Front Surg; 2021; 8():712350. PubMed ID: 34722621
[No Abstract] [Full Text] [Related]
30. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
[TBL] [Abstract][Full Text] [Related]
31. The effects of tumor size and postoperative radiotherapy for patients with adult low-grade (WHO grade II) infiltrative supratentorial astrocytoma/oligodendroglioma: A population-based and propensity score matched study.
Lin DD; Deng XY; Zheng DD; Gu CH; Yu LS; Xu SY; Li DD; Fang JH; Yin B; Sheng HS; Lin J; Zhang XL; Zhang N
Cancer Med; 2018 Dec; 7(12):5973-5987. PubMed ID: 30378290
[TBL] [Abstract][Full Text] [Related]
32. Anaplastic astrocytoma and anaplastic oligodendroglioma occurring 6 years after subtotal resection of a central neurocytoma. Case report.
Kanamori M; Kumabe T; Watanabe M; Tominaga T
J Neurosurg; 2007 Jul; 107(1):185-9. PubMed ID: 17639893
[TBL] [Abstract][Full Text] [Related]
33. [A molecular classification system for anaplastic glioma].
Jiang HH; Ren XH; Zhang Z; Lin S
Zhonghua Wai Ke Za Zhi; 2013 Dec; 51(12):1104-9. PubMed ID: 24499721
[TBL] [Abstract][Full Text] [Related]
34. Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma.
Winger MJ; Macdonald DR; Cairncross JG
J Neurosurg; 1989 Oct; 71(4):487-93. PubMed ID: 2552044
[TBL] [Abstract][Full Text] [Related]
35. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.
McGirt MJ; Chaichana KL; Attenello FJ; Weingart JD; Than K; Burger PC; Olivi A; Brem H; Quinoñes-Hinojosa A
Neurosurgery; 2008 Oct; 63(4):700-7; author reply 707-8. PubMed ID: 18981880
[TBL] [Abstract][Full Text] [Related]
36. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO
Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621
[TBL] [Abstract][Full Text] [Related]
37. The presence of necrosis and/or microvascular proliferation does not influence survival of patients with anaplastic oligodendroglial tumours: review of 98 patients.
Smith SF; Simpson JM; Brewer JA; Sekhon LH; Biggs MT; Cook RJ; Little NS
J Neurooncol; 2006 Oct; 80(1):75-82. PubMed ID: 16794749
[TBL] [Abstract][Full Text] [Related]
38. Canadian brain cancer survival rates by tumour type and region: 1992-2008.
Yuan Y; Shi Q; Li M; Nagamuthu C; Andres E; Davis FG
Can J Public Health; 2016 Jun; 107(1):e37-e42. PubMed ID: 27348108
[TBL] [Abstract][Full Text] [Related]
39. Oligodendroglioma: does deferring treatment compromise outcome?
Feigenberg SJ; Amdur RJ; Morris CG; Mendenhall WM; Marcus RB; Friedman WA
Am J Clin Oncol; 2003 Jun; 26(3):e60-6. PubMed ID: 12796617
[TBL] [Abstract][Full Text] [Related]
40. Treatment updates regarding anaplastic oligodendroglioma and anaplastic oligoastrocytoma.
Khan KA; Abbasi AN; Ali N
J Coll Physicians Surg Pak; 2014 Dec; 24(12):935-9. PubMed ID: 25523732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]